[HTML][HTML] Astrocytes in human central nervous system diseases: a frontier for new therapies

A Verkhratsky, A Butt, B Li, P Illes, R Zorec… - … and Targeted Therapy, 2023 - nature.com
Astroglia are a broad class of neural parenchymal cells primarily dedicated to homoeostasis
and defence of the central nervous system (CNS). Astroglia contribute to the …

[HTML][HTML] The contribution of microglia to neuroinflammation in Parkinson's disease

K Badanjak, S Fixemer, S Smajić, A Skupin… - International Journal of …, 2021 - mdpi.com
With the world's population ageing, the incidence of Parkinson's disease (PD) is on the rise.
In recent years, inflammatory processes have emerged as prominent contributors to the …

Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation

K Wasner, S Smajic, J Ghelfi, S Delcambre… - Movement …, 2022 - Wiley Online Library
Background Mutations in the E3 ubiquitin ligase parkin cause autosomal recessive
Parkinson's disease (PD). Together with PTEN‐induced kinase 1 (PINK1), parkin regulates …

[HTML][HTML] Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation

C Wang, T Yang, M Liang, J Xie, N Song - Translational …, 2021 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder that primarily affects the
elderly. While the etiology of PD is likely multifactorial with the involvement of genetic …

[HTML][HTML] Unlocking neural function with 3D in vitro models: A technical review of self-assembled, guided, and bioprinted brain organoids and their applications in the …

C D'Antoni, L Mautone, C Sanchini, L Tondo… - International Journal of …, 2023 - mdpi.com
Understanding the complexities of the human brain and its associated disorders poses a
significant challenge in neuroscience. Traditional research methods have limitations in …

[HTML][HTML] Astrocytic atrophy as a pathological feature of Parkinson's disease with LRRK2 mutation

P Ramos-Gonzalez, S Mato, JC Chara… - npj Parkinson's …, 2021 - nature.com
The principal hallmark of Parkinson's disease (PD) is the selective neurodegeneration of
dopaminergic neurones. Mounting evidence suggests that astrocytes may contribute to …

[HTML][HTML] Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites

JM Tokarew, DN El-Kodsi, NA Lengacher, TK Fehr… - Acta …, 2021 - Springer
The mechanisms by which parkin protects the adult human brain from Parkinson disease
remain incompletely understood. We hypothesized that parkin cysteines participate in redox …

[HTML][HTML] Astrocytes in neurodegeneration: inspiration from genetics

J Huang, C Li, H Shang - Frontiers in neuroscience, 2022 - frontiersin.org
Despite the discovery of numerous molecules and pathologies, the pathophysiology of
various neurodegenerative diseases remains unknown. Genetics participates in the …

Pathogenesis of Parkinson's disease: from hints from monogenic familial PD to biomarkers

N Hattori, M Funayama, Y Imai, T Hatano - Journal of Neural Transmission, 2024 - Springer
Twenty-five years have passed since the causative gene for familial Parkinson's disease
(PD), Parkin (now PRKN), was identified in 1998; PRKN is the most common causative gene …

[HTML][HTML] The age of brain organoids: Tailoring cell identity and functionality for normal brain development and disease modeling

LO Porciúncula, L Goto-Silva, PF Ledur… - Frontiers in …, 2021 - frontiersin.org
Over the past years, brain development has been investigated in rodent models, which were
particularly relevant to establish the role of specific genes in this process. However, the …